Loading organizations...
Key people at 21stBio.
21st.BIO develops a precision fermentation technology platform, integrating advanced microbial strain engineering, fermentation expertise, and bioprocess development. This robust platform provides high-performance, cost-effective solutions for producing alternative proteins and various specialty ingredients, enabling sustainable biomanufacturing across diverse applications.
Thomas Schmidt and Per Falholt founded 21st.BIO in 2020, driven by the insight that precision fermentation could address significant global challenges. These seasoned scientists and business leaders, with extensive backgrounds in industrial biotechnology and food science, established the company to make this powerful technology broadly accessible.
The company's offerings are designed for industry players seeking advanced biomanufacturing capabilities. 21st.BIO's mission is to democratize precision fermentation, making it accessible and affordable, thereby fostering sustainable protein innovation and contributing to global food security and environmental sustainability.
Key people at 21stBio.
21stBio has 1 tracked investment across 1 company. The latest tracked deal is $20.0M Series A in Reshape Biotech in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2024 | Reshape Biotech | $20.0M Series A | PER Falholt, Astanor Ventures | ACME Capital, Charlie Songhurst, Nicholas Francis, Acme, R7 Partners, Y Combinator |